Clinical Trials · NCT03569241

PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases

Active Not RecruitingPhase 2Gonadorelin (Investigational)
Phase
Phase 2
Recruitment status
Active Not Recruiting
Sponsor
University Hospital, Ghent
Enrollment
196
Start date
Apr 2018
Locations
29 sites, 6 countries
Primary endpoint
Metastases-free survival
View Gonadorelin compound reference